NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email CEO Donna Murray-Brown looks to build on work the statewide women’s business organization has done since its beginning in 1961.Read More